Judge overrules Trump effort to advertise drug prices
A federal judge in the US has said that the Trump administration cannot require pharmaceutical companies to include drug prices in advertisements as it is beyond their authority.
List view / Grid view
A federal judge in the US has said that the Trump administration cannot require pharmaceutical companies to include drug prices in advertisements as it is beyond their authority.
PR001 has received Fast Track Designation from the regulatory body for the treatment of Parkinson’s disease.
The 34th and, so far, biggest edition of Chemspec Europe attracted a total of 4,295 trade visitors from 53 countries to the exhibition grounds of Messe Basel, Switzerland. From 26 to 27 June 2019, a total of 379 exhibitors from 27 countries presented their innovative substances on a record net…
Two pharmaceutical companies have partnered to develop a slow-release drug to treat patients with HIV.
Pharmaceutical packaging in China has increased at a rate of 10 percent in recent years and is predicted to continue high growth.
MIT researchers have developed an algorithm which uses a new technique to predict missing data from clinical trial information.
Seven medications have been suggested for removal from prescriptions by the NHS after a public consultation.
The rise of diseases such as inflammatory bowel syndrome is projected to drive the global gastrointestinal drugs market in the upcoming years.
The EU has issued two guidance documents intended to advise the pharmaceutical industry and patients during medicinal shortages.
Vizimpro (dacomitinib) has been recommended as a first-line treatment option for patients with lung cancer.
New regulations and legislations are being formed in the US to combat healthcare costs, including drug prices.
The DHSC has announced their plans for pharmaceutical transportation in the case of a no-deal Brexit.
A research group has designed a pills-on-a-coil system to administer drugs without having to take pills.
A pharmaceutical company will appeal a decision by NICE to not recommend osimertinib for use within NHS England.
Accelerated approval has been granted to Xpovio to treat refractory multiple myeloma by the FDA.